Vulva Vocab Survey

ISSWSH Online Learning Modules

VISIT ELEARNING.ISSWSH.ORG

For members, please login first by clicking here. On this page please click on ISSM University under the Resources tab.

cme

Amedco LLC designates this internet activity enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM for each module.

Female Sexual Dysfunction Nomenclature and Epidemiology
Dr. S. Althof, Dr. A. Clayton and Dr. S. Parish
This Module presents the epidemiology, prevalence, classification systems, and models for female sexual disorders. The historical development of sexual disorders in the DSM and the changes in definitions in the transition from DSM IV-TR to DSM 5, as well as new ISSWSH, endorsed nomenclature are also discussed. Lastly, foundational knowledge on the neurobiology related to female sexual function and dysfunction and its importance to clinical practice is presented.

Hormone Dependent Sexual Dysfunctions in Pre and Postmenopausal Women Including GSM and OCP Use
Dr. A. Goldstein, Dr. T. Rowen and Dr. J. Simon
This learning module recognizes the clinical manifestations of GSM and the underlying pathology and apply evidence-based treatment options, both hormonal and non-hormonal, to the management of GSM and describes the potential positive and negative sexual health effects of various contraceptive methods. It is comprised of three video segments, including: Genitourinary Syndrome of Menopause – Prevalence, Symptoms and Treatments; Vestibulodynia – Epidemiology and Diagnosis; Breast Cancer, Aromatase Inhibitors and SERMs.

How to Take a Sexual History, Screen a Patient, and Utilize Relevant Health Questionnaires
Dr. S. Faubion, Dr. S. Kingsberg and Dr. T. Rowen
Sexual health is an important aspect of wellness and many patients have sexual health concerns. Yet, the majority of health care practitioners do not routinely assess sexual health. This module provides practical advice on taking sexual histories and using relevant sexual health questionnaires.

Management of Arousal Disorders, From Anatomy Through Diagnosis to Treatment
Dr. L. Larkin, Dr. L. Millheiser and Dr. R. Rubin
This learning module summarizes the nomenclature, basic physiology, and principles in the clinical evaluation and management of female arousal disorders. The learning objectives are to understand different etiologies of arousal disorders and adopt a holistic approach in evaluating and managing arousal disorders.

Management of Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD): Neurophysiology, Diagnosis and Treatment
B. Faught, Dr. I. Goldstein, Dr. N. Kim and Dr. J. Simon
This learning module cites the rational and logical use of treatments affecting central excitatory neurotransmitters and describes the rational and logical use of treatments affecting central inhibitory neurotransmitters. It is comprised of four video segments, including: HSDD Definition, Prevalence, Neurophysiology and Introduction to HSDD Process of Care; Hormonal Therapy for HSDD; Pharmacological Therapies for HSDD; Summary of ISSWSH Process of Care for HSDD.

Management of Orgasm Disorders, From Anatomy Through Diagnosis to Treatment
Dr. I. Goldstein, Dr. S. Kingsberg and Dr. B. Komisaruk
This learning module summarizes the nomenclature, neurophysiology, and principles in the clinical evaluation and management of female orgasmic disorders. The learning objectives are to differentiate among different types of orgasm disorders and describe various aspects of orgasm compromise.

Management of Persistent Genital Arousal Disorder, From Anatomy Through Diagnosis to Treatment
Dr. I. Goldstein, Dr. J. Pfaus and Dr. R. Rubin
This learning module characterizes the underlying pathophysiologies leading to PGAD and the associate therapeutic strategies with specific pathophysiologies of PGAD. It is comprised of four video segments, including: Sexual Pain in Women: Anatomy & Assessment; Peripheral and Central Mechanisms of Persistent Genital Arousal Disorder; Management of Persistent Genital Arousal Disorder – Peripheral Causes; Management of Persistent Genital Arousal Disorder – Central Causes.

Management of Sexual Pain Disorders; From Anatomy Through Diagnosis to Treatment
Dr. A. Goldstein, Dr. I. Goldstein and Dr. S. Kellogg-Spadt
This learning module summarizes the epidemiology, anatomy, etiology and associated risk factors and principles in the clinical evaluation and management of sexual pain disorders in women. The learning objectives are to learn the prevalence and the three most common causes of dyspareunia; learn the important components of the physical exam for a woman with dyspareunia; and describe the possible sources of sexual pain and relevant treatment options.

Understanding Hormone Therapy and the Roles of Estrogen, Androgens, and Progestogens
Dr. S. Parish, Dr. T. Rowen and Dr. J. Simon
This learning module applies relevant data and appropriate individual choices to the education of both HCPs and patients in order to guide them through the process of menopausal hormone therapy decision-making and analyzes the major differences in available hormone therapies to help individualize the treatment and enhance the benefits while decreasing the risks for the menopausal patient. The module discusses the safety and efficacy of testosterone therapy in women, identifying the benefits and risks associated with off label testosterone use and helps the learner to understand the differences between various progestogens. It is comprised of five video segments, including: Introduction to Understanding Sex Steroid Hormones; Menopausal Estrogen and Hormone Therapy: Understanding the Real Risks and Benefits; Understanding Sex Steroid Hormones: Androgens; Sex Steroids: Understanding progesterone and progestins; Addressing Concerns of the Menopausal Patient – Mock Interview.

VISIT ELEARNING.ISSWSH.ORG

CME INFORMATION

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Physicians
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for the Study of Women’s Sexual Health (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

VISIT ELEARNING.ISSWSH.ORG

Role of Biotechnology and Pharmaceutical Companies in Developing Novel Therapies for Female Sexual Dysfunction

Female sexual disorders have historically been treated with multiple non-medical and off-label medical therapies by a limited number of experienced clinicians. Yet, most therapies have insufficient clinical evidence to support their safety and efficacy. Thus, the development of safe and effective therapies for the treatment of sexual disorders in women is critical to improving the overall management of these conditions, and increasing access to care. The International Society for the Study of Women’s Sexual Health (ISSWSH) supports the role of biotechnology and pharmaceutical companies, and other investigators developing novel therapies for female sexual dysfunction. ISSWSH rejects a “one size fits all” approach to treating female sexual dysfunction due to the multiplicity of biopsychosocial factors that impact sexual health. The concept of personalized medicine, and the availability of multiple therapeutic options are critical in this field.

Slide Deck Order Form

Order the 2022 ISSWSH Slide Deck today! An updated 400+ slide resource on Female Sexual Function and Dysfunction.

Purchasing this resource acts as agreement to use this material for educational purposes only.

As of June 20, 2023, purchase the 2022 Slide Deck and also receive the 2023 Slide Deck when it becomes available at no additional cost!

Please see the Table of Contents below for more information on what is covered in the slide deck.


Fill out your NAME and EMAIL (IMPORTANT! We will email the slide deck to the email you provide on this form) and click on the "Buy Now" button.

Pricing


Members:
 (log in to get the discounted price)

  • $45.00
  • $15.00 (for members who purchased the 2017, 2018, 2019, 2020 or 2021 ISSWSH Slide Deck to upgrade to the updated 2022 version)

Non-members: 

  • $145.00
  • $45.00 (for non-members who purchased the 2017, 2018, 2019, 2020 or 2021 ISSWSH Slide Deck to upgrade to the updated 2022 version)


Members: After login, you can find the Slide Deck order form under Resources in the navigation bar.

Non-Member order form

Type
Your name
Your email

Purchasing this resource acts as agreement to use this material for educational purposes only.

2022 Slide Deck Table of Contents
  • Epidemiology and Definitions (3-27)
  • Anatomy and Pathophysiology (28-36)
  • Sexual History Taking (37-72)
    • Process of Care for the Identification of Sexual Concerns and Problems in Women (55-72)
  • Underrepresented and Vulnerable Populations (73-133)
    • LGBTQ+ (73-106)
    • Women of Color (107-119)
    • Victims of Sexual Violence (120-133)
  • Female Sexual Dysfunction (134-304)
    • Hypoactive Sexual Desire Disorder (134-146)
    • HSDD Management Process of Care (147-189)
    • Female Sexual Arousal Disorder (190-199)
    • Persistent Genital Arousal Disorder (200-228)
    • Orgasm Disorders (229-247)
    • Sexual Pain Disorders (248-274)
      • Vulvar Skin Disorders (275-304)
  • Female Sexual Dysfunction in Special Circumstances (305-458)
    • Aging/Menopause/GSM (305-334)
      • Menopausal Hormone Therapy (335-353)
    • Testosterone Use in Women (354-374)
    • Infertility (375-380)
    • Family Planning and Sexual Function (381-403)
    • Pregnancy and Postpartum (404-420)
    • Gynecologic Cancer (421-433)
    • Benign Gynecologic Conditions (434-445)
    • Psychiatric Disorders (446-458)
  • Treatment of Female Sexual Dysfunction (459-481)
    • Lubricants, Moisturizers, Vibrators (459-470)
    • Sex Therapy Approaches (471-481)

 

Subcategories

If you have a book you would like listed below, please contact the ISSWSH office at (952) 683-9025 or email This email address is being protected from spambots. You need JavaScript enabled to view it..

The material and links are added to this site as a benefit of ISSWSH Membership. ISSWSH does not qualify or endorse the information contained or referenced below unless specifically noted.


Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow Us

On Twitter
On Facebook
On Instagram

Subscribe

Subscribe to the ISSWSH Newsletter so sou don't miss any ISSWSH news!